Medical Products Company
BTG has acquired 8 companies of its own, including 3 in the last 5 years. A total of 4 acquisitions came from private equity firms. It has also divested 1 asset.
BTG’s largest acquisition to date was in 2014, when it acquired PneumRx for $475M. It’s largest disclosed sale occurred in 2009, when it sold HySolv Technology to Novartis AG for $10M. BTG has acquired in 3 different US states, and 3 countries. The Company’s most targeted sectors include medical products (84%) and life science (17%).
Join Mergr and gain access to BTG’s M&A summary, the M&A summaries of companies just like it, as well as recent M&A activity in the medical products sector.
M&A Summary
-
M&A Total Activity7
- M&A Buy Activity6
- M&A Sell Activity1
- Total Sectors Invested 2
- Total Countries Invested 3
- M&A Buy/Sell Connections 7
- M&A Advisors 2
Unlimited Searches
